News for Research Solutions, Inc. (RSSS)

**media[602747]**

\nInvestment rationale: Strategic acquisitions enhancing market position.Market positioning: Strengthening presence in academic and B2C markets.Risks and challen

Maine-based Synergy CHC Corp. (SNYR) is up over 139 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

We recently compiled a list of the 12 Best AI Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Research Solutions, Inc.

PR NewswireHENDERSON, Nev., March 20, 2025 New Model Delivers Substantial Performance Improvements In Quality & DepthHENDERSON, Nev., March 20, 2025 /PRNew

PR NewswireHENDERSON, Nev., March 10, 2025 New Solution Supports Growing Demand for AI-Enabled Research & Development Market, Enabling Research Efficiency

Texas-based Moleculin Biotech, Inc. (MBRX), a clinical stage pharmaceutical company is up over 53 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

Research Solutions (RSSS) reports record ARR growth, AI-driven platform enhancements, and strategic sales restructuring in Q2 2025.

Research Solutions, Inc. (NASDAQ:RSSS) Q2 2025 Earnings Conference Call February 13, 2025 5:00 PM ETCompany ParticipantsSteven Hooser - Investor...

Research Solutions Inc (RSSS) is set to release its Q2 2025 earnings on Feb 13, 2025. The consensus estimate for Q2 2025 revenue is $11.83 million, and the earn

Research Solutions (RSSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

We recently published a list of 12 Must-See AI News and Ratings You Might Have Missed. In this article, we are going to take a look at where Research Solutions, Inc.

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a [url="]new way[/url] to provide genetic couns

Here is how Research Solutions Inc. (RSSS) and ScanSource (SCSC) have performed compared to their sector so far this year.

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Research Solutions (RSSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

On November 15, 2024, Cove Street Capital, LLC (Trades, Portfolio) made a strategic decision to reduce its position in Research Solutions Inc (RSSS). The firm d

PR NewswireHENDERSON, Nev., Nov. 19, 2024 SaaS Executive with Track Record of Accelerating GrowthHENDERSON, Nev., Nov. 19, 2024 /PRNewswire/ -- Research So

Research Solutions, Inc. (NASDAQ:RSSS) Q1 2025 Earnings Conference Call November 14, 2024 5:00 PM ETCompany ParticipantsSteven Hooser - IRRoy Olivier -...